| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |